KeyBank National Association’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

KeyBank National Association’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-9,837	Closed	-$1.12M	–	1109
2022 Q4	$1.12M	Sell	9,837 -816	-8%	-$67.8K	0.01%	445
2022 Q3	$659K	Sell	10,653 -242	-2%	-$16.9K	﹤0.01%	560
2022 Q2	$869K	Sell	10,895 -585	-5%	-$55.4K	﹤0.01%	493
2022 Q1	$1.21M	Sell	11,480 -6,741	-37%	-$657K	0.01%	463
2021 Q4	$1.96M	Sell	18,221 -17,874	-50%	-$1.95M	0.01%	404
2021 Q3	$3.95M	Sell	36,095 -4,191	-10%	-$435K	0.02%	292
2021 Q2	$3.77M	Buy	40,286 +2,548	+7%	+$234K	0.02%	299
2021 Q1	$3.47M	Sell	37,738 -3,866	-9%	-$326K	0.02%	303
2020 Q4	$3.04M	Buy	41,604 +5,634	+16%	+$419K	0.01%	304
2020 Q3	$2.79M	Sell	35,970 -12,606	-26%	-$867K	0.02%	299
2020 Q2	$2.7M	Buy	48,576 +23,201	+91%	+$993K	0.02%	307
2020 Q1	$752K	Buy	25,375 +16,100	+174%	+$545K	0.01%	505
2019 Q4	$336K	Sell	9,275 -229	-2%	-$7.02K	﹤0.01%	833
2019 Q3	$259K	Sell	9,504 -1,146	-11%	-$29.6K	﹤0.01%	875
2019 Q2	$256K	Buy	10,650 +301	+3%	+$7.63K	﹤0.01%	909
2019 Q1	$274K	Sell	10,349 -337	-3%	-$7.99K	﹤0.01%	851
2018 Q4	$209K	Buy	+10,686	New	+$209K	﹤0.01%	883
2015 Q1	–	Sell	-12,404	Closed	-$160K	–	1261
2014 Q4	$160K	Sell	12,404 -10,192	-45%	-$128K	﹤0.01%	1174
2014 Q3	$277K	Sell	22,596 -26,336	-54%	-$306K	﹤0.01%	1062
2014 Q2	$774K	Buy	48,932 +2,883	+6%	+$41.1K	0.01%	759
2014 Q1	$696K	Sell	46,049 -52,034	-53%	-$588K	0.01%	776
2013 Q4	$747K	Sell	98,083 -43,640	-31%	-$235K	﹤0.01%	765
2013 Q3	$475K	Buy	141,723 +16,154	+13%	+$42.6K	﹤0.01%	894
2013 Q2	$309K	Buy	+125,569	New	+$301K	﹤0.01%	1126

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

KeyBank National Association's HZNP Position: Q1 2023 in Review

KeyBank National Association sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2023, closing a stake of 9,837 shares — an estimated $1.12M sold.

KeyBank National Association first reported a position in HZNP in Q2 2013 and held it in 24 quarters. The position peaked at $3.95M in Q3 2021. 553 funds tracked by Wall St. Rank hold HZNP as of Q1 2023.

KeyBank National Association reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2023 after selling out during the quarter.
KeyBank National Association sold 9,837 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2023, an estimated $1.12M.
KeyBank National Association first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2013 and held it in 24 quarters.
KeyBank National Association's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $3.95M in Q3 2021.
553 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2023.

Based on KeyBank National Association's 13F filing for Q1 2023, filed 10 May 2023.